F2R and neoplasm: Thrombin also potently activates platelets, which also accumulate in clots, and it interacts with cellular signalling receptors (e.g., protease activated receptor 1-PAR-1) on various cells whereby it exerts multiple regulatory effects across the tumour microenvironment (56).